List of works by Judith Trotman

Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma.

scientific article published on June 2016

Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic

scientific article published on 15 May 2020

Author reply

scientific article published in October 2019

Baseline Metabolic Tumor Volume Predicts Outcome in High-Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies.

scientific article published on 22 August 2016

Consensus guidelines for 'rainy day' autologous stem cell harvests in New South Wales.

scientific article

Deliverability and efficacy of R-CHOP chemotherapy in very elderly patients with diffuse large B-cell lymphoma: an Australian retrospective analysis

scientific article published on 4 September 2015

Does end-of-treatment FDG-PET improve outcomes in follicular lymphoma? - Authors' reply

scientific article published on 01 January 2019

Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14

scientific article published on 10 November 2016

Epstein Barr virus-positive mucocutaneous ulcer of the colon associated Hodgkin lymphoma in Crohn's disease

scientific article published on May 2015

Evaluating the place of 18-fluoro-2-deoxy-D-glucose positron emission tomography scanning in primary staging and beyond in patients with follicular lymphoma.

scientific article published in October 2013

First-Line Treatment of Patients With Indolent Non-Hodgkin Lymphoma or Mantle-Cell Lymphoma With Bendamustine Plus Rituximab Versus R-CHOP or R-CVP: Results of the BRIGHT 5-Year Follow-Up Study

scientific article published on 27 February 2019

Formalising multidisciplinary peer review: developing a haematological malignancy-specific electronic proforma and standard operating procedure to facilitate procedural efficiency and evidence-based clinical practice

scientific article

Front-line management of indolent non-Hodgkin lymphoma in Australia. Part 2: mantle cell lymphoma and marginal zone lymphoma

scientific article published on 01 September 2019

Front-line management of non-Hodgkin lymphoma in Australia. Part 1: follicular lymphoma

scientific article published on 01 April 2019

Haemorrhagic cystitis: incidence and risk factors in a transplant population using hyperhydration

scientific article published on 01 April 1999

High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantation

scientific article published on 15 February 2016

High total metabolic tumor volume at baseline predicts survival independent of response to therapy

scientific article published on 01 April 2020

Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study.

scientific article

Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial.

scientific article

Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety

scientific article published on 01 June 2018

Invasive pneumococcal disease in central Australia.

scientific article published on June 1995

Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.

scientific article published on 20 April 2017

Lenalidomide maintenance for diffuse large B-cell lymphoma patients responding to R-CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study

scientific article published on 08 November 2019

Management of patients with follicular lymphoma treated first line with obinutuzumab

scientific article published on 01 May 2019

PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study

scientific article published on 8 January 2016

PET/CT assessment in follicular lymphoma using standardized criteria: central review in the PRIMA study

scientific article published on 17 January 2014

Pharmacokinetics of melphalan in myeloma patients undergoing an autograft

scientific article published on 06 August 2007

Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL

scientific article published on 24 July 2019

Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy.

scientific article

Positron emission tomography-computed tomography in follicular lymphoma: "one fit for all"?

scientific article published on 21 January 2015

Primary objective of Concord Haematology Clinical Research Unit is to contribute independently to quality clinical research

scientific article published on 01 June 2020

Prognostic model for high tumor burden follicular lymphoma integrating baseline and end induction PET: a LYSA/FIL study.

scientific article published on 20 March 2018

Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studies

scientific article published on 17 September 2014

Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial

article

Randomized Phase III Study of Alisertib or Investigator's Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma

scientific article published on 01 February 2019

Rapidly fatal post-allogeneic stem cell transplant lymphoproliferative disorder presenting with skin and bone marrow involvement.

scientific article published in January 2013

Reply to B. Bennani-Baiti et al, H.J.A. Adams et al, E. Laffon et al, and E.A. Hawkes et al

scientific article published on 17 February 2015

Reply to G. Keramida et al.

scientific article published on 24 August 2015

Reply to H.J.A. Adams et al and E. Laffon et al

scientific article published on 28 December 2016

Retrospective pharmaceutical financial benefits and cost avoidance analysis of clinical trial participation in the Australian haematology setting

scientific article published on 01 September 2019

Rising cost of anticancer drugs in Australia.

scientific article published in May 2014

Role of early PET in the management of diffuse large B-cell lymphoma.

scientific article published on September 2010

Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.

scientific article published on September 2014

Severe hemolysis and transfusion reactions after treatment with BGB-3111 and PD-1 antibody for Waldenström Macroglobulinemia.

scientific article published on 8 February 2018

Subacute cardiac toxicity following autologous haematopoietic stem cell transplantation in patients with normal cardiac function

scientific article published on 10 December 2007

TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets

scientific article published on 17 December 2014

Time to publish: challenging the performance of cooperative group lymphoma trials

scientific article published in December 2016

Treatment of patients with Waldenström macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group.

scientific article published in January 2017

Upfront lower dose lenalidomide is less toxic and does not compromise efficacy for vulnerable patients with relapsed refractory multiple myeloma: final analysis of the phase II RevLite study

scientific article published on 15 February 2017

Using scenarios to explain life expectancy in advanced cancer: attitudes of people with a cancer experience.

scientific article published on 21 June 2012

Paulina is supported by:

About Paulina

Help